Summit Therapeutics Inc. Common Stock drawdown: 54.3% below the all-time high
Summit Therapeutics Inc. Common Stock is 54.3% below its all-time high, set Apr 24, 2025 (as of market close, Oct 2, 2026). The chart shows every day as a percentage of the highest level reached up to that point: 100% means a fresh record, everything below is a drawdown.
- Below all-time high
- −54.3%
- 45.7% of ATH
- All-time high
- $36.7
- Apr 24, 2025
- Time below the high
- 17 mo
- since Apr 24, 2025
- Worst-ever drawdown
- −95.8%
- Dec 1, 2022
- Longest underwater
- 7.0 yrs
- between all-time highs
- Today's level first reached
- Sep 9, 2024
- 2.1 yrs ago
- Last time this deep
- Jul 5, 2024
- in a previous episode
% of all-time high since 2015#
The classic underwater chart (drawdown curve), drawn as % of the all-time high — 100% is a fresh record, everything below it is time spent underwater. Basis and range are in the URL, so a particular view is a link.
The deepest drawdowns on record#
Every decline of 15% or more from an all-time high (price basis), deepest first.
| Peak | Trough | Depth | Peak → trough | Recovered by | Underwater |
|---|---|---|---|---|---|
| Sep 11, 2017 | Dec 1, 2022 | −95.8% | 5.2 yrs | Sep 9, 2024 | 7.0 yrs |
| Apr 24, 2025 | Aug 20, 2026 | −66.1% | 16 mo | not yet | 17 mo+ |
| Apr 6, 2015 | Sep 15, 2016 | −59.8% | 17 mo | Oct 4, 2016 | 18 mo |
| Sep 13, 2024 | Apr 8, 2025 | −47.9% | 7 mo | Apr 23, 2025 | 7 mo |
| Oct 5, 2016 | Dec 29, 2016 | −43.4% | 3 mo | Aug 7, 2017 | 10 mo |
| Aug 7, 2017 | Aug 14, 2017 | −16.8% | 7 days | Sep 7, 2017 | 31 days |
Price basis (no dividends) — the convention crash histories use. With dividends reinvested, recoveries arrive years earlier; switch the basis on the chart above to see it.
Drawdown vs what came next#
One dot per month since 2015: how far Summit Therapeutics Inc. Common Stock stood below its all-time high, and the total return over the following 1, 5 and 10 years.
Read this with survivorship bias in mind: a single asset's history is one surviving sample, so past recoveries here say little about the odds ahead. Monthly windows also overlap heavily (they are not independent samples). Not investment advice.
FAQ#
- How far is Summit Therapeutics Inc. Common Stock from its all-time high?
- Summit Therapeutics Inc. Common Stock is currently 54.3% below its all-time high, set Apr 24, 2025 (as of market close, Oct 2, 2026). Prices only, the convention headlines use; with dividends reinvested the gap is usually smaller.
- What was the biggest Summit Therapeutics Inc. Common Stock drawdown ever?
- The deepest decline on record in our data (since 2015) took Summit Therapeutics Inc. Common Stock 95.8% below its prior high, bottoming Dec 1, 2022. The table on this page lists every major episode with its peak, trough and recovery date.
Methodology & related#
Daily data since -1 from SMMT; no free deep history exists for Summit Therapeutics Inc. Common Stock — for a 150-year drawdown record see the S&P 500 drawdown page. The price basis excludes dividends; the total-return basis reinvests them; the real basis additionally deflates by CPI. See also returns by year. Past performance does not predict future returns; not investment advice.